Jun 2, 2022 | Cancer Center News
Photo credit: College of Veterinary Medicine A trial led by Dr. Tim Fan at Illinois will evaluate safety and effectiveness of cANK-101 in dogs with oral malignant melanoma. This canine drug was developed by Ankyra Therapeutics, a Boston-based biotech company, using...
Nov 19, 2020 | Cancer Center News
ILLINOIS — A desire to improve the status of cancer patient treatments led former theoretical physicist, Jun Song (PhD), to pivot his career towards cancer research. He spent several years learning about cancer biology and retraining to apply his background in...
